US EditionPBMs Are Breaking Down Barriers to Expand Access to Biosimilars and Lower Consumer Costs
Summary by PCMA
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
PBMs Are Breaking Down Barriers to Expand Access to Biosimilars and Lower Consumer Costs
While Drug Companies Drive Up Drug Prices with Anti-Competitive Behavior, PBMs Continue to Innovate and Lower Costs for Consumers As policymakers tackle America’s prescription drug affordability challenge, it’s important to remember that Big Pharma sets the price of the prescription drugs – and the price is the number one problem when it comes to Americans facing difficulty affording their prescription drugs. Drug companies raise drug prices yea…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
